Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M60.8Revenue $M0.8Net Margin (%)-12,279.7Altman Z-Score-14.6
Enterprise Value $M28.0EPS $-2.9Operating Margin %-12,282.7Piotroski F-Score3
P/E(ttm)--Beneish M-Score-5.7Pre-tax Margin (%)-12,297.0Higher ROA y-yY
Price/Book5.310-y EBITDA Growth Rate %--Quick Ratio3.4Cash flow > EarningsY
Price/Sales1305-y EBITDA Growth Rate %--Current Ratio3.4Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-92.3Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-157.4Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M21.7ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with ONTX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ONTXGeorge Soros 2014-09-30 Sold Out $4.325 - $5.64
($5.07)
$ 2.74-46%Sold Out0
ONTXGeorge Soros 2014-06-30 Buy $4.18 - $6.22
($5.24)
$ 2.74-48%New holding10,774
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ONTX is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


ONTX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Michael & Jane Hoffman 2013 De10% Owner 2014-02-21Buy143,480$8.47-67.65 view
Hoffman Michael BDirector, 10% Owner 2014-02-21Buy143,480$8.47-67.65 view
Kumar RameshPresident and CEO 2014-02-10Sell33,543$15.07-81.82 view
Kumar RameshPresident and CEO 2014-02-03Sell60,000$15.05-81.79 view
Hoffman Michael BDirector, 10% Owner 2014-01-27Buy57,295$11.92-77.01 view
Michael & Jane Hoffman 2013 De10% Owner 2014-01-27Buy57,295$11.92-77.01 view
Michael & Jane Hoffman 2013 De10% Owner 2013-11-22Buy5,000$14.39-80.96 view
Hoffman Michael BDirector, 10% Owner 2013-11-22Buy5,000$14.39-80.96 view
Reddy E PremkumarDirector 2013-11-18Buy5,000$12.1-77.36 view
Hoffman Michael BDirector, 10% Owner 2013-11-18Buy5,000$11.87-76.92 view

Press Releases about ONTX :

    Quarterly/Annual Reports about ONTX:

    News about ONTX:

    Articles On GuruFocus.com
    Weekly 3-Year Low Highlights: VCRA, CLUB, ARGS, ONTX, BOTA Jun 08 2014 

    More From Other Websites
    ONCONOVA THERAPEUTICS, INC. Financials May 22 2015
    Onconova Therapeutics (ONTX) Looks Good: Stock Up 5.8% - Tale of the Tape May 18 2015
    Onconova Therapeutics (ONTX) Shares March Higher, Can It Continue? - Tale of the Tape May 18 2015
    ONCONOVA THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report May 15 2015
    What's in Store for Autodesk (ADSK) in Q1 Earnings? - Analyst Blog May 15 2015
    Why Onconova Therapeutics (ONTX) Might Surprise This Earnings Season - Tale of the Tape May 15 2015
    Will Kite Pharma (KITE) Miss Earnings Estimates Yet Again? - Analyst Blog May 14 2015
    Onconova Therapeutics, Inc. Reports Recent Business Highlights and First Quarter 2015 Financial... May 14 2015
    ONCONOVA THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... May 14 2015
    Onconova Therapeutics, Inc. Reports Recent Business Highlights and First Quarter 2015 Financial... May 14 2015
    Onconova Announces Multiple Rigosertib Clinical Data Presentations at the 2015 ASCO Annual Meeting May 13 2015
    Onconova Announces Multiple Rigosertib Clinical Data Presentations at the 2015 ASCO Annual Meeting May 13 2015
    Will Immune Design (IMDZ) Miss on Earnings This Season? - Analyst Blog May 13 2015
    4 Speculative Biotechs With Huge Analyst Targets May 09 2015
    LifeSci Capital Initiates Coverage of Onconova Therapeutics May 08 2015
    Coverage initiated on Onconova Therapeutics by H.C. Wainwright May 05 2015
    Onconova Presenting Nine Abstracts Related to Rigosertib at the 13th International Symposium on... May 01 2015
    Onconova Presenting Nine Abstracts Related to Rigosertib at the 13th International Symposium on... May 01 2015
    Onconova Therapeutics, Inc. Highlights Rigosertib and Early-stage Programs at the 2015 American... Apr 21 2015
    Onconova Therapeutics, Inc. Highlights Rigosertib and Early-stage Programs at the 2015 American... Apr 21 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK